Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439576
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-05-28
Brief Title:
Real World Evidence in China Faricimab Use in Diabetic Macular Edema Retinal Vein Occlusion and Neovascular Age-Related Macular Degeneration The Farseeing Study
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Organization Data
Organization:
Hoffmann-La Roche
Class:
INDUSTRY
Study ID:
ML45401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoffmann-La Roche
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shanghai Roche Pharmaceutical Co Ltd | UNKNOWN |